- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03513224
The eDosette Pilot Study
April 19, 2018 updated by: Henry Siu, McMaster University
The Use of an Electronic Medication Administration-monitoring Device to Improve Medication Adherence and Reduce Medication Regimen Complexity in Community Dwelling Seniors: A Prospective Pilot Study
Medication non-adherence can lead to serious health issues for older adults.
This study is a four week study in older adults using a new device, the eDosette, which dispenses and records how one takes their medications, and subsequently makes this information available to the primary care team by the internet.
This study aims to show that the eDosette can report how well a group of older adults living independently in the community are taking their medications (e.g.
"medication adherence").
This study hopes to show that the eDosette intervention could play a role in medication adherence by improving conversations between older adults and primary care.
Study Overview
Study Type
Interventional
Enrollment (Actual)
57
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age 65 and over
- taking five or more medications (including supplements)
- using or willing to use a blister pack or dosette
- currently managing their medications independently
- living independently
- English speaking
Exclusion Criteria:
- a documented diagnosis of mild cognitive impairment or dementia
- living in any form of assisted living facility
- currently palliative
- currently deemed medically unstable by their primary care team
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: eDosette
|
The eDosette is an internet-enabled, medication administration monitoring unit that has been previously tested for feasibility in older adults.
The eDosette was designed to be compatible with different types of weekly medication blister packs and dosettes, and monitors medication-taking behaviour in a patient's home.
The eDosette securely transmits this information to a secure server where the information is converted to individual medication administration records.
Patients can also use the eDosette to notify their primary care team of potential medication side effects.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Four-week medication adherence rate
Time Frame: 4 weeks
|
Each participant's observed medication adherence for the entire study was calculated by dividing the total medication doses taken correctly by the total doses in the study.
The numerator, total medication doses taken correctly is calculated by subtracting from the total doses any missed or late doses as determined by the eDosette.
Missed doses is defined as any dose still present on image data after the next daily scheduled dose time); late doses is defined as any dose taken outside the two-hour time window of the average time of dose administration - e.g.
08h00-10h00 for a 09h00 average dose time.
The denominator, total doses, was defined as the total number of pills prescribed for a patient to take during the study.
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Thematic content of pharmacist-participant discussion during the study
Time Frame: 4 weeks
|
Retrospective chart reviews were performed to extract content on these discussions.
|
4 weeks
|
Frequency of medication changes noted
Time Frame: 4 weeks
|
Retrospective chart reviews were performed to extract content on these changes.
|
4 weeks
|
Change in MRCI score
Time Frame: 4 weeks
|
Medication Regimen Complexity Index (MRCI) were calculated at baseline and 4 weeks by the pharmacist based on medication listed obtained from dispensing pharmacies.
|
4 weeks
|
Participant feedback
Time Frame: 4 weeks
|
An exit-feedback survey was administered asking participants to rank their experience with the eDosette.
The survey also asked participants to identify the three best and worst aspects of the eDosette.
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2016
Primary Completion (Actual)
August 31, 2017
Study Completion (Actual)
December 31, 2017
Study Registration Dates
First Submitted
April 19, 2018
First Submitted That Met QC Criteria
April 19, 2018
First Posted (Actual)
May 1, 2018
Study Record Updates
Last Update Posted (Actual)
May 1, 2018
Last Update Submitted That Met QC Criteria
April 19, 2018
Last Verified
April 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- CAT2015-25
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Medication Adherence
-
NYU Langone HealthRobert Wood Johnson Foundation; New York City Health and Hospitals CorporationCompletedMedication Adherence | Medication ErrorsUnited States
-
Universiti Putra MalaysiaCompletedMedication Adherence | Adherence, TreatmentPakistan
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingMedication Adherence | Medication ComplianceUnited States
-
Vanderbilt University Medical CenterCompletedAdherence, Medication | Nonadherence, MedicationUnited States
-
Universidad Autonoma de Baja CaliforniaCompletedMedication Adherence | Medication ComplianceMexico
-
University Hospital, Basel, SwitzerlandUniversity of BaselCompletedPolymedication-Check With Insight in Patients' Medication Organisation and Comprehension of GenericsMedication Adherence | Medication Therapy ManagementSwitzerland
-
Cliniques universitaires Saint-Luc- Université...RecruitingAdherence, MedicationBelgium
-
Northwell HealthNational Institute on Aging (NIA)RecruitingMedication AdherenceUnited States
-
Swedish Medical CenterNational Institute of Mental Health (NIMH); University of Washington; University...Recruiting
-
Northwell HealthToronto Dominion BankCompletedMedication AdherenceUnited States